Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 201: Which drug can be given in G-6-P-D deficiency?

A. Chloroquine
B. Probenecid (Correct Answer)
C. Amidopyrine
D. Primaquine

Explanation: **Explanation:** Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is an X-linked recessive disorder where RBCs are unable to regenerate NADPH, making them vulnerable to oxidative stress. When exposed to certain drugs, hemoglobin denatures into **Heinz bodies**, leading to acute hemolysis. **Why Probenecid is the correct answer:** While older literature occasionally listed Probenecid as a potential trigger, modern evidence-based classifications (such as those by the G6PD Deficiency Association) categorize **Probenecid as safe** to use at therapeutic doses. It does not possess significant oxidative potential compared to the other drugs listed. **Analysis of Incorrect Options:** * **Primaquine (Option D):** This is the classic "high-risk" drug. It is a potent oxidant and is **absolutely contraindicated** in G6PD deficiency as it causes severe hemolysis. Patients must be screened for G6PD levels before starting radical cure for *P. vivax*. * **Amidopyrine (Option C):** This is an older NSAID/analgesic known to be a definite trigger for hemolytic crises in G6PD-deficient individuals. * **Chloroquine (Option A):** While generally considered safer than Primaquine, Chloroquine is still classified as a drug that can induce hemolysis in certain variants of G6PD deficiency (especially the Mediterranean type) and is typically avoided if safer alternatives exist. **NEET-PG High-Yield Pearls:** * **Mnemonic for G6PD Triggers:** "**S**ell **P**a**N**IC **D**rugs" (**S**ulfonamides, **P**rimaquine, **N**itrofurantoin, **I**soniazid, **C**hloramphenicol, **D**apsone). * **Fava beans** (Favism) are a classic non-drug trigger. * **Diagnosis:** Peripheral smear shows **Heinz bodies** and **Bite cells** (degluticytes). * **Key Concept:** In G6PD deficiency, the most common cause of hemolysis is actually **infection**, not just drugs.

Question 202: Which of the following monoclonal antibodies can be used in Clostridium difficile infection?

A. Canakinumab
B. Dupilumab
C. Certolizumab
D. Bezlotoxumab (Correct Answer)

Explanation: **Explanation:** **Correct Answer: D. Bezlotoxumab** **Mechanism and Rationale:** *Clostridium difficile* infection (CDI) causes pathology primarily through the release of two exotoxins: **Toxin A (Enterotoxin)** and **Toxin B (Cytotoxin)**. While antibiotics like Vancomycin or Fidaxomicin target the bacteria itself, **Bezlotoxumab** is a human monoclonal antibody that binds specifically to **Toxin B**. By neutralizing the toxin, it prevents damage to the intestinal mucosa and significantly reduces the risk of **recurrent CDI** in high-risk patients. It is administered as a single intravenous infusion. **Analysis of Incorrect Options:** * **A. Canakinumab:** An **Interleukin-1β (IL-1β) inhibitor** used in systemic juvenile idiopathic arthritis and periodic fever syndromes. * **B. Dupilumab:** An **IL-4 and IL-13 receptor antagonist** used in the management of moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis. * **C. Certolizumab:** A **TNF-alpha inhibitor** (specifically a PEGylated Fab' fragment) used in Crohn’s disease and rheumatoid arthritis. **High-Yield Clinical Pearls for NEET-PG:** * **Bezlotoxumab vs. Actoxumab:** While Bezlotoxumab targets Toxin B, Actoxumab (targets Toxin A) was also studied but did not show clinical efficacy on its own. * **Drug of Choice for CDI:** Oral **Fidaxomicin** or oral **Vancomycin** are first-line agents. Metronidazole is now reserved for non-severe cases where other options are unavailable. * **Key Side Effect:** Use Bezlotoxumab with caution in patients with **congestive heart failure (CHF)**, as it may exacerbate the condition.

Question 203: What is the recommended treatment for latent syphilis?

A. Penicillin (Correct Answer)
B. Erythromycin
C. Tetracycline
D. Ciprofloxacin

Explanation: **Explanation:** **Penicillin G** remains the gold standard and drug of choice for all stages of syphilis, including latent syphilis, caused by the spirochete *Treponema pallidum*. The underlying medical concept is that *T. pallidum* is exquisitely sensitive to Penicillin, and no documented resistance has emerged in decades. For latent syphilis, the goal is to maintain a treponemicidal concentration of the drug in the blood for an extended period. * **Early Latent Syphilis:** Treated with a single intramuscular dose of **Benzathine Penicillin G (2.4 million units)**. * **Late Latent Syphilis (or unknown duration):** Requires three doses of **Benzathine Penicillin G** at weekly intervals to ensure eradication of the slow-dividing organisms. **Why other options are incorrect:** * **Erythromycin (B):** While macrolides were used in the past, high rates of resistance have made them unreliable. They also do not cross the placental barrier effectively, making them unsuitable for preventing congenital syphilis. * **Tetracycline/Doxycycline (C):** These are considered **second-line** alternatives only for non-pregnant patients with a severe penicillin allergy. They are less effective and require longer treatment courses (14–28 days). * **Ciprofloxacin (D):** Fluoroquinolones have no significant clinical activity against *T. pallidum* and are not used in the management of syphilis. **High-Yield Clinical Pearls for NEET-PG:** 1. **Jarisch-Herxheimer Reaction:** An acute febrile reaction occurring within 24 hours of starting penicillin in syphilis patients due to the release of endotoxins from dying spirochetes. It is managed with aspirin/NSAIDs. 2. **Neurosyphilis:** Must be treated with **Aqueous Crystalline Penicillin G** (IV) to achieve adequate CSF concentrations; Benzathine penicillin is insufficient for CNS involvement. 3. **Pregnancy:** Penicillin is the **only** recommended treatment. If a pregnant woman is allergic, she must undergo **penicillin desensitization**.

Question 204: All are dihydrofolate reductase antagonists, EXCEPT?

A. Methotrexate
B. Cytosine arabinoside (Correct Answer)
C. Pentamidine
D. Pyrimethamine

Explanation: **Explanation:** The question asks to identify the drug that does **not** inhibit the enzyme **Dihydrofolate Reductase (DHFR)**. **1. Why Cytosine Arabinoside (Ara-C) is the correct answer:** Cytosine arabinoside is a **pyrimidine antimetabolite**. Its mechanism of action involves being phosphorylated into its active form (ara-CTP), which then inhibits **DNA polymerase** and gets incorporated into DNA, leading to chain termination. It does not interfere with the folic acid pathway or DHFR. **2. Why the other options are incorrect (DHFR Inhibitors):** These drugs act by competitively inhibiting DHFR, preventing the conversion of dihydrofolate to tetrahydrofolate, which is essential for DNA synthesis. * **Methotrexate:** A potent DHFR inhibitor used in cancer chemotherapy and as a disease-modifying antirheumatic drug (DMARD). * **Pyrimethamine:** An antiprotozoal agent used primarily in the treatment of toxoplasmosis and malaria. * **Pentamidine:** An antiprotozoal drug used for *Pneumocystis jirovecii* pneumonia; it possesses multiple mechanisms, one of which includes DHFR inhibition. **High-Yield Clinical Pearls for NEET-PG:** * **Selective Toxicity:** Trimethoprim (antibacterial) and Pyrimethamine (antiprotozoal) have a higher affinity for microbial DHFR, whereas Methotrexate is highly specific for human DHFR. * **Rescue Therapy:** Leucovorin (folinic acid) is used to "rescue" normal cells from Methotrexate toxicity because it bypasses the DHFR step. * **Mnemonic for DHFR Inhibitors:** "**P**yrimethamine, **M**ethotrexate, **P**rimethoprim, **P**roguanil, **P**entamidine" (The **5 P's**). * **Cytosine Arabinoside** is the most effective single agent for inducing remission in **Acute Myeloid Leukemia (AML)**.

Question 205: A 37-year-old immunosuppressed patient with renal failure develops sepsis. Which of the following antibiotics, if used, would require a major reduction in dosage?

A. Erythromycin
B. Doxycycline
C. Tobramycin (Correct Answer)
D. Isoniazid

Explanation: **Explanation:** The core concept tested here is the **route of elimination** of antimicrobial agents. In patients with renal failure, drugs primarily excreted unchanged by the kidneys require significant dose adjustments to prevent toxicity. **Why Tobramycin is correct:** Tobramycin is an **Aminoglycoside**. Aminoglycosides are highly polar, water-soluble molecules that are excreted almost entirely (90%+) via **glomerular filtration** in an unchanged form. In renal failure, their clearance decreases proportionally with the Creatinine Clearance (CrCl). Failure to reduce the dose or increase the dosing interval leads to accumulation, significantly increasing the risk of **nephrotoxicity** and **ototoxicity**. **Why the other options are incorrect:** * **Erythromycin:** This macrolide is primarily metabolized by the liver and excreted in the **bile**. No major dose adjustment is needed in renal failure. * **Doxycycline:** Unlike other tetracyclines, doxycycline is excreted mainly via the **feces** (enterohepatic circulation). It is the "tetracycline of choice" in renal failure. * **Isoniazid:** This antitubercular drug undergoes **hepatic acetylation**. While metabolites are excreted renally, a major dose reduction is generally not required unless there is concurrent hepatic impairment. **High-Yield NEET-PG Pearls:** * **"Safe" in Renal Failure:** Ceftriaxone, Doxycycline, Erythromycin, Clindamycin, and Linezolid (no major adjustment). * **Contraindicated in Renal Failure:** Tetracycline (except Doxycycline), Nitrofurantoin, and Nalidixic acid. * **Aminoglycoside Monitoring:** Therapeutic Drug Monitoring (TDM) is essential. They exhibit **concentration-dependent killing** and a significant **post-antibiotic effect (PAE)**.

Question 206: Which of the following drugs CANNOT be used to treat infections caused by Bacteroides fragilis?

A. Metronidazole
B. Trovafloxacin
C. Vancomycin
D. Amikacin (Correct Answer)

Explanation: **Explanation:** The correct answer is **Amikacin**. **1. Why Amikacin is the correct answer:** *Bacteroides fragilis* is an obligate anaerobic gram-negative rod. The fundamental mechanism of action for **Aminoglycosides** (like Amikacin) requires an **oxygen-dependent active transport system** to cross the bacterial cell membrane. Since anaerobes lack the oxygen required for this transport, they are intrinsically resistant to all aminoglycosides. Therefore, Amikacin has no activity against *B. fragilis*. **2. Analysis of Incorrect Options:** * **Metronidazole (Option A):** This is the "gold standard" for anaerobic infections. It is a prodrug that is activated by the enzyme *pyruvate-ferredoxin oxidoreductase*, found only in anaerobes, leading to DNA strand breakage. * **Trovafloxacin (Option B):** While most fluoroquinolones have poor anaerobic activity, Trovafloxacin (a fourth-generation fluoroquinolone) was specifically developed to have a broad spectrum that includes potent activity against *B. fragilis*. * **Vancomycin (Option C):** While Vancomycin is primarily used for Gram-positive infections (like MRSA), it is effective against most Gram-positive anaerobes. However, it is important to note that while it is not the first choice for *B. fragilis* (which is Gram-negative), the question asks what *cannot* be used; Amikacin is the absolute contraindication due to the physiological impossibility of its uptake. **3. NEET-PG High-Yield Pearls:** * **Anaerobic Coverage Mnemonic:** "Can't Breathe Fresh Air" (**C**lindamycin, **B**-lactam/B-lactamase inhibitors, **F**lagyl/Metronidazole, **A**naerobic Quinolones like Moxifloxacin/Trovafloxacin). * **Aminoglycoside Resistance:** Anaerobes are **intrinsically resistant** due to the lack of oxygen-dependent transport. * **Synergy:** Aminoglycosides are often combined with Cell Wall Synthesis Inhibitors (like Penicillins) to facilitate entry into the cell, but this still requires an aerobic environment to reach the ribosome.

Question 207: Which sulfonamide eye drop is used clinically?

A. Sulfacetamide (Correct Answer)
B. Sulfamethoxazole
C. Sulfinpyrazone
D. All of the above

Explanation: **Explanation:** **Sulfacetamide sodium** is the correct answer because it is the only sulfonamide specifically formulated for ophthalmic use. Its clinical utility stems from its **high aqueous solubility** and ability to achieve high concentrations in ocular tissues. Unlike other sulfonamides, it is non-irritating to the eye at the neutral pH required for topical application. It is primarily used for the treatment of bacterial conjunctivitis and as adjunctive therapy in trachoma. **Analysis of Incorrect Options:** * **Sulfamethoxazole:** This is a systemic sulfonamide typically used in combination with trimethoprim (as Co-trimoxazole) for UTIs, respiratory infections, and *Pneumocystis jirovecii* pneumonia. It is not used as an eye drop. * **Sulfinpyrazone:** This is a **uricosuric agent** used in the management of chronic gout. Although it is a sulfonamide derivative, it lacks antimicrobial activity and is used to inhibit the renal tubular reabsorption of uric acid. * **All of the above:** Incorrect, as only Sulfacetamide has an ophthalmic indication. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Sulfonamides are structural analogs of PABA; they competitively inhibit **Dihydropteroate Synthase**, preventing bacterial folic acid synthesis (Bacteriostatic). * **Mnemonic for Ophthalmic Sulfas:** Remember **"S for Soluble, S for Sulfacetamide"** to recall its use in eye drops. * **Silver Sulfadiazine & Mafenide:** These are other topical sulfonamides, but they are used for **burn dressings** to prevent *Pseudomonas* infections, not for ophthalmic use. * **Adverse Effect:** Topical sulfonamides can rarely trigger Stevens-Johnson Syndrome (SJS) in sensitized individuals.

Question 208: Retrobulbar neuritis is seen with which of the following drugs?

A. Rifampicin
B. Streptomycin
C. Ethambutol (Correct Answer)
D. Ethionamide

Explanation: **Explanation:** **Ethambutol** is a bacteriostatic first-line antitubercular drug that inhibits the enzyme **arabinosyl transferase**, thereby interfering with cell wall synthesis. Its most characteristic and dose-dependent side effect is **optic neuritis**, specifically **retrobulbar neuritis**. * **Mechanism of Toxicity:** Ethambutol acts as a chelating agent that depletes copper in the retinal ganglion cells, leading to mitochondrial dysfunction. * **Clinical Presentation:** Patients typically present with decreased visual acuity, central scotoma, and a characteristic **loss of red-green color discrimination**. Since it is "retrobulbar," the optic disc often appears normal during early fundoscopy. **Analysis of Incorrect Options:** * **Rifampicin:** Known for causing a harmless **orange-red discoloration** of body fluids (urine, sweat, tears) and hepatotoxicity. * **Streptomycin:** An aminoglycoside that causes **ototoxicity** (specifically vestibular damage) and nephrotoxicity. It does not affect the optic nerve. * **Ethionamide:** A second-line drug that primarily causes intense GI irritation, hepatotoxicity, and peripheral neuropathy (due to its structural similarity to Isoniazid). **NEET-PG High-Yield Pearls:** 1. **Monitoring:** Patients on Ethambutol should undergo baseline and monthly visual acuity and color vision testing (using Ishihara charts). 2. **Reversibility:** The ocular toxicity is usually reversible upon drug discontinuation, but recovery is slow. 3. **Contraindication:** It is generally avoided in children below 6 years of age because they cannot reliably report changes in vision. 4. **Renal Adjustment:** Ethambutol is primarily excreted by the kidneys; dose adjustment is required in renal failure to prevent toxicity.

Question 209: What is the drug of choice to treat severe fungal infections in patients with AIDS?

A. Acyclovir
B. Ketoconazole (Correct Answer)
C. Aerosolized pentamidine
D. Didanosine

Explanation: **Explanation:** The correct answer is **Ketoconazole**. In the context of this specific question (often based on classic pharmacological teaching for competitive exams), Ketoconazole is identified as a primary oral antifungal used for systemic or severe fungal infections in immunocompromised patients, such as those with AIDS, particularly before the widespread availability of newer triazoles like Fluconazole. **Why Ketoconazole is correct:** Ketoconazole is an imidazole derivative that inhibits the enzyme **14-α-demethylase**, preventing the conversion of lanosterol to ergosterol, a vital component of the fungal cell membrane. In AIDS patients, it has historically been used to treat mucocutaneous candidiasis and other systemic mycoses due to its broad spectrum of activity. **Analysis of Incorrect Options:** * **A. Acyclovir:** This is an **antiviral** agent used specifically for Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV). It has no activity against fungal pathogens. * **C. Aerosolized pentamidine:** This is used for the prophylaxis or treatment of *Pneumocystis jirovecii* pneumonia (PCP) in AIDS patients. While *P. jirovecii* is technically a fungus, pentamidine is an antiprotozoal/antifungal agent specifically targeted at PCP and is not used for general "severe fungal infections." * **D. Didanosine (ddI):** This is a **Nucleoside Reverse Transcriptase Inhibitor (NRTI)** used in the HAART regimen to treat HIV itself, not the opportunistic fungal infections that result from it. **NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC) Update:** While this question highlights Ketoconazole, modern clinical practice often prefers **Amphotericin B** for life-threatening systemic infections and **Fluconazole** for maintenance therapy in AIDS patients due to better penetration and fewer side effects. * **Side Effects:** Ketoconazole is notorious for inhibiting mammalian cytochrome P450 enzymes, leading to **gynecomastia** and decreased libido due to the inhibition of testosterone synthesis. * **Absorption:** Ketoconazole requires an **acidic gastric pH** for absorption; therefore, avoid co-administration with H2 blockers or PPIs.

Question 210: Thioacetazone has cross-resistance with which of the following drugs?

A. Isoniazid (INH)
B. Rifampicin
C. Ethionamide (Correct Answer)
D. Ethambutol

Explanation: **Explanation:** The correct answer is **Ethionamide**. **Why Ethionamide is correct:** Thioacetazone and Ethionamide are both members of the **thioamide** group of antitubercular drugs. They share a similar chemical structure and a common mechanism of action: both act as prodrugs that are activated by the monooxygenase enzyme **EthA**. Once activated, they inhibit the enzyme **InhA** (enoyl-ACP reductase), which is essential for mycolic acid synthesis in the mycobacterial cell wall. Because they utilize the same activation pathway (EthA), a mutation in the *ethA* gene leads to resistance in both drugs, resulting in **cross-resistance** [5]. **Why other options are incorrect:** * **Isoniazid (INH):** While INH also inhibits the InhA enzyme, it is activated by a different enzyme, **KatG** (catalase-peroxidase). Therefore, resistance to INH (usually via KatG mutation) does not automatically confer resistance to Thioacetazone [5]. * **Rifampicin:** This drug acts by inhibiting DNA-dependent RNA polymerase (rpoB gene). Its mechanism is entirely distinct from mycolic acid synthesis inhibitors [4]. * **Ethambutol:** This drug inhibits arabinosyl transferase, interfering with the synthesis of arabinogalactan in the cell wall. It does not share a metabolic pathway or target with Thioacetazone. **High-Yield Clinical Pearls for NEET-PG:** * **Thioacetazone & HIV:** Thioacetazone is strictly contraindicated in HIV-positive patients due to the high risk of life-threatening **Stevens-Johnson Syndrome (SJS)** and Toxic Epidermal Necrolysis (TEN). * **Ethionamide Side Effects:** It is notorious for causing intense GI irritation and a metallic taste [5]. * **Cross-resistance Summary:** Always remember the

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free